Christiane Gold-Schneider

St Josef Hospital
Bochum, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 69 publications

Gefurulimab-The First Effective Nanobody in Myasthenia Gravis Therapy.

Gefurulimab-The First Effective Nanobody in Myasthenia Gravis Therapy.

Journal: JAMA neurology

Published: July 27, 2026

Virtual reality-based oculography detects internuclear ophthalmoplegia in multiple sclerosis and other neurological disorders.

Virtual reality-based oculography detects internuclear ophthalmoplegia in multiple sclerosis and other neurological disorders.

Journal: Journal of neurology

Published: March 19, 2026

OCT-Based Differentiation of First Acute Optic Neuritis: An International Study of 111 Patients With NMOSD and MOGAD.

OCT-Based Differentiation of First Acute Optic Neuritis: An International Study of 111 Patients With NMOSD and MOGAD.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: January 07, 2026

Early versus late add-on therapy in generalized myasthenia gravis: a multicenter real-world cohort study.

Early versus late add-on therapy in generalized myasthenia gravis: a multicenter real-world cohort study.

Journal: Journal of neurology

Published: December 24, 2025

Longitudinal Evaluation of Polyneuropathy in Atypical Parkinsonian Syndromes.

Longitudinal Evaluation of Polyneuropathy in Atypical Parkinsonian Syndromes.

Journal: Neurology international

Published: November 30, 2025

Anti-CD19 CAR T-Cell Therapy in Advanced Stiff-Person Syndrome and Concomitant Myasthenia Gravis.

Anti-CD19 CAR T-Cell Therapy in Advanced Stiff-Person Syndrome and Concomitant Myasthenia Gravis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: October 06, 2025

Cortical thinning and white matter alterations in myotonic dystrophy type 2 over a 10-year period.

Cortical thinning and white matter alterations in myotonic dystrophy type 2 over a 10-year period.

Journal: Journal of neurology

Published: July 17, 2025

Repeat-associated ataxias in a German patient cohort analysed by targeted parallel long-read sequencing.

Repeat-associated ataxias in a German patient cohort analysed by targeted parallel long-read sequencing.

Journal: Brain : a journal of neurology

Published: March 06, 2025

Repeat-associated ataxias in a German patient cohort analysed by targeted parallel long-read sequencing.

Repeat-associated ataxias in a German patient cohort analysed by targeted parallel long-read sequencing.

Journal: Brain : a journal of neurology

Published: March 06, 2025

Therapies for myasthenia gravis: FcRn inhibition and beyond.

Therapies for myasthenia gravis: FcRn inhibition and beyond.

Journal: The Lancet. Neurology

Published: December 09, 2024

The role of CNBP in brain atrophy and its targeting in myotonic dystrophy type 2.

The role of CNBP in brain atrophy and its targeting in myotonic dystrophy type 2.

Journal: Human molecular genetics

Published: October 02, 2024

C5 complement inhibition versus FcRn modulation in generalised myasthenia gravis.

C5 complement inhibition versus FcRn modulation in generalised myasthenia gravis.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: June 05, 2024

Showing 1-12 of 69

Last Updated: 09/26/2026